Delivery Order SPE2DB22D2006-SPE2DB25FW4CA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,685.66 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 ml syringes. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure. Performance will be completed by August 28, 2025, with the contract issued on August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $3,580.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes on August 19, 2025. The contract, designated as a non-set-aside competitive award, is scheduled for completion by September 10, 2025, with performance taking place at the awardee's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Kineret 100 mg/0.67 mL syringes, with a contract ceiling value of $7,161.76 and an ultimate completion date of September 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Kineret 100 mg/0.67 mL syringes totaling $14,323.52, with completion targeted for May 15, 2025. The contract utilizes firm fixed pricing with no set-aside designation, reflecting competitive award procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Kineret 100 mg/0.67 mL syringes with a ceiling value of $4,476.10 under a firm fixed-price contract. The order is scheduled for completion by September 15, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order that reflects the standard procurement approach used...
- The Defense Logistics Agency awarded a delivery order valued at $7,161.76 to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes on September 2, 2025, with completion scheduled for September 23, 2025. This competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Kineret (anakinra) is a recombinant human interleukin-1 receptor antagonist used to treat inflammatory conditions, representing...
- The Defense Logistics Agency awarded a $3,580.88 delivery order to AmerisourceBergen Drug Corp for Kineret (anakinra) 100 mg/0.67 mL syringes on August 14, 2025, with a completion date of September 5, 2025. This firm fixed-price contract, which carries no set-aside designation, reflects a competitive award to the pharmaceutical distributor for delivery to its corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Kineret 100 mg/0.67 mL syringes. The contract is valued at $3,580.88 with a firm fixed price structure and an ultimate completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,371.32 firm fixed-price delivery order is for the provision of Kineret 100 mg/0.67 ml syringes. The contract has a period of performance through July 17, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This delivery order, valued at $3,580.88, was awarded on September 8, 2025, to AmerisourceBergen Drug Corp for the supply of Kineret 100 mg/0.67 mL syringes to support federal medical procurement needs. The contract is non-set-aside and competitively awarded under firm fixed pricing terms, with performance to be completed by September 29, 2025, at the awardee's corporate office in Conshohocken, Pennsylvania. The Defense Logistics Agency, under the Department of Defense, issued this delivery...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW4CADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,580.88 to AmerisourceBergen Drug Corp for Kineret 100 mg/0.67 mL syringes on September 9, 2025, with completion targeted for September 30, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 vehicle running through December 2026 that provides comprehensive global pharmaceutical support. The parent contract enables the contractor to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs worldwide. The Defense Logistics Agency is planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen Drug Corp to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/9/25 |